USPH U S PHYSICAL THERAPY revenue, earnings and financials

For the quarter ended June 30, 2026, U S PHYSICAL THERAPY reported revenue of $214M (up 8.5% from a year earlier), net income of $9.90M and diluted EPS of $0.25; over the last four quarters revenue was $812M and net income $32.2M; for the fiscal year ended December 2025 revenue was $781M, up 16.3% on the year before.

USPH annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $781M, gross profit $150M, operating income $86.7M, net income $39.6M (margin 5.1%), EPS $1.42
• Fiscal year ended Dec 2024: revenue $671M, gross profit $124M, operating income $63.0M, net income $31.4M (margin 4.7%), EPS $1.84
• Fiscal year ended Dec 2023: revenue $605M, gross profit $122M, operating income $50.5M, net income $28.2M (margin 4.7%), EPS $1.28
• Fiscal year ended Dec 2022: revenue $553M, gross profit $112M, operating income $56.8M, net income $32.2M (margin 5.8%), EPS $2.25
• Fiscal year ended Dec 2021: revenue $495M, gross profit $117M, operating income $70.6M, net income $40.8M (margin 8.2%), EPS $2.41

USPH quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $214M (up 8.5% year over year), net income $9.90M, EPS $0.25
• Quarter ended Mar 31, 2026: revenue $198M (up 7.9% year over year), net income $5.04M, EPS −$0.12
• Quarter ended Dec 31, 2025 (from the annual report): revenue $203M (up 12.3% year over year), net income $4.15M, EPS −$0.44
• Quarter ended Sep 30, 2025: revenue $197M (up 17.3% year over year), net income $13.1M, EPS $0.48
• Quarter ended Jun 30, 2025: revenue $197M (up 18.0% year over year), net income $12.4M, EPS $0.58
• Quarter ended Mar 31, 2025: revenue $184M (up 18.1% year over year), net income $9.90M, EPS $0.80
• Quarter ended Dec 31, 2024 (from the annual report): revenue $180M (up 16.6% year over year), net income $9.24M, EPS $0.52
• Quarter ended Sep 30, 2024: revenue $168M (up 12.0% year over year), net income $6.63M, EPS $0.39
• Quarter ended Jun 30, 2024: revenue $167M (up 10.4% year over year), net income $7.51M, EPS $0.47
• Quarter ended Mar 31, 2024: revenue $156M (up 4.8% year over year), net income $8.05M, EPS $0.46
• Quarter ended Dec 31, 2023 (from the annual report): revenue $155M (up 9.6% year over year), net income $656K, EPS −$0.45
• Quarter ended Sep 30, 2023: revenue $150M (up 7.5% year over year), net income $9.25M, EPS $0.51
• Quarter ended Jun 30, 2023: revenue $151M (up 7.7% year over year), net income $10.9M, EPS $0.64
• Quarter ended Mar 31, 2023: revenue $149M (up 12.8% year over year), net income $7.41M, EPS $0.58
• Quarter ended Dec 31, 2022 (from the annual report): revenue $141M (up 8.7% year over year), net income $2.61M, EPS −$0.01
• Quarter ended Sep 30, 2022: revenue $140M (up 10.9% year over year), net income $9.56M, EPS $0.72
• Quarter ended Jun 30, 2022: revenue $141M (up 10.8% year over year), net income $11.2M, EPS $0.87
• Quarter ended Mar 31, 2022: revenue $132M (up 17.2% year over year), net income $8.80M, EPS $0.67
• Quarter ended Dec 31, 2021 (from the annual report): revenue $130M, net income $10.2M, EPS $0.72
• Quarter ended Sep 30, 2021: revenue $126M, net income $10.0M, EPS $0.66

USPH cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $75.1M, share buybacks $5.57M, dividends $1.80 per share
• Fiscal year ended Dec 2024: operating cash flow $74.9M, share buybacks $0, dividends $1.76 per share
• Fiscal year ended Dec 2023: operating cash flow $82.0M, share buybacks $0, dividends $1.72 per share
• Fiscal year ended Dec 2022: operating cash flow $58.5M, share buybacks n/a, dividends $1.64 per share
• Fiscal year ended Dec 2021: operating cash flow $76.4M, share buybacks n/a, dividends $1.46 per share

USPH balance sheet

• Jun 30, 2026: cash $24.9M, total assets $1.25B, total liabilities $482M, shareholders' equity $449M, long-term debt $215M
• Mar 31, 2026: cash $28.4M, total assets $1.24B, total liabilities $459M, shareholders' equity $469M, long-term debt $194M
• Dec 31, 2025: cash $35.6M, total assets $1.20B, total liabilities $434M, shareholders' equity $476M, long-term debt $153M
• Sep 30, 2025: cash $31.1M, total assets $1.20B, total liabilities $414M, shareholders' equity $504M, long-term debt $151M
• Jun 30, 2025: cash $34.1M, total assets $1.18B, total liabilities $414M, shareholders' equity $501M, long-term debt $152M
• Mar 31, 2025: cash $39.2M, total assets $1.18B, total liabilities $421M, shareholders' equity $497M, long-term debt $157M
• Dec 31, 2024: cash $41.4M, total assets $1.17B, total liabilities $408M, shareholders' equity $489M, long-term debt $143M
• Sep 30, 2024: cash $117M, total assets $1.03B, total liabilities $358M, shareholders' equity $483M, long-term debt $133M

What is USPH's revenue?

U S PHYSICAL THERAPY reported $812M of revenue over its last four quarters, through June 30, 2026.

Is USPH profitable?

Yes. U S PHYSICAL THERAPY earned $32.2M over the last four quarters.

What is USPH's EPS?

Diluted earnings per share over the last four quarters were $0.17; $0.25 in the latest quarter.

Does USPH pay a dividend?

U S PHYSICAL THERAPY paid $1.80 per share in dividends in the fiscal year ended December 2025.

USPH ownership and insider trades · All stocks